Long-term outcomes of graves disease in children treated with anti-thyroid drugs
Background: Graves disease (GD) is the most common cause of thyrotoxicosis in children and adolescents, accounting for 15% of all thyroid diseases during childhood. Anti-thyroid drugs (ATD) are recommended as the first-line treatment in children and adolescents. However, the remission rate is lower...
Saved in:
| Main Authors: | Ya-Ting Chiang, Wei-Hsin Ting, Chi-Yu Huang, Shih-Kang Huang, Chon-In Chan, Bi-Wen Cheng, Chao-Hsu Lin, Yi-Lei Wu, Chen-Mei Hung, Hsin-Jung Li, Chia-Jung Chan, Yann-Jinn Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957219305595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyroid peroxidase antibodies and their role in predicting outcomes in Graves’ disease treatment
by: Klara Gewert, et al.
Published: (2025-04-01) -
Characteristics of patients with Graves’ disease who developed drug resistance and required surgery
by: Yusuke Shibata, et al.
Published: (2025-04-01) -
Thyroidectomy versus antithyroid drugs in Graves’ disease: a meta-analysis of randomized controlled trials
by: XiaoGang Zheng, et al.
Published: (2025-07-01) -
High-dose versus low-dose block-and-replace treatment for a first episode of Graves’ disease
by: Arnaud Smolders, et al.
Published: (2025-04-01) -
Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves’ disease: literature review
by: Akshat Sinha, et al.
Published: (2025-05-01)